Avadel Pharmaceuticals plc (AVDL) has a market capitalization of $2.12B and trades at $21.64. The 52-week range is 6.38-23.57.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -42.4, Earnings Per Share (EPS) of $-0.51, annual revenue of $169.12M.
The stock has a beta of 1.31, operates in the Healthcare sector.
